Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Florian Moik, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Hoeller, Felix Tuchmann, Marie-Bernadette Aretin, Thorsten Fuereder, Sabine Zöchbauer-Müller, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Blood (2021) 137 (12): 1669–1678.

https://doi.org/10.1182/blood.2020007878

Published: 2021

Includes: Supplemental data

Journal Articles

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

Ruth Scheicher, Andrea Hoelbl-Kovacic, Florian Bellutti, Anca-Sarmiza Tigan, Michaela Prchal-Murphy, Gerwin Heller, Christine Schneckenleithner, María Salazar-Roa, Sabine Zöchbauer-Müller, Johannes Zuber, Marcos Malumbres, Karoline Kollmann, Veronika Sexl

Blood (2015) 125 (1): 90–101.

https://doi.org/10.1182/blood-2014-06-584417

Published: 2015

Includes: Supplemental data

Journal Articles

Next Generation Sequencing Identifies DNA Methylation Patterns Indicative of Disease Progression in Ph + CML

Gerwin Heller, PhD, Thais Topakian, Corinna Altenberger, MSc, Sabine Cerny-Reiterer, Dr., Barbara Ziegler, Paul Datlinger, MSc, Christoph Bock, PhD, Christine Mannhalter, PhD, Gregor Hörmann, MD PhD, Wolfgang R Sperr, MD, Christoph C Zielinski, MD, Peter Valent, MD, Sabine Zöchbauer-Müller, MD

Blood (2014) 124 (21): 4526.

https://doi.org/10.1182/blood.V124.21.4526.4526

Published: 2014

Journal Articles

5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS- demethylation and FAS re-expression, and synergism with FAS-ligand

Viviane Ghanim, Harald Herrmann, Gerwin Heller, Barbara Peter, Emir Hadzijusufovic, Katharina Blatt, Karina Schuch, Sabine Cerny-Reiterer, Irina Mirkina, Heidrun Karlic, Winfried F. Pickl, Sabine Zöchbauer-Müller, Peter Valent

Blood (2012) 119 (18): 4242–4252.

https://doi.org/10.1182/blood-2011-09-382770

Published: 2012

Includes: Supplemental data

Journal Articles

c-JUN promotes BCR-ABL–induced lymphoid leukemia by inhibiting methylation of the 5′ region of Cdk6

Karoline Kollmann, Gerwin Heller, Rene Georg Ott, Ruth Scheicher, Eva Zebedin-Brandl, Christine Schneckenleithner, Olivia Simma, Wolfgang Warsch, Eva Eckelhart, Andrea Hoelbl, Martin Bilban, Sabine Zöchbauer-Müller, Marcos Malumbres, Veronika Sexl

Blood (2011) 117 (15): 4065–4075.

https://doi.org/10.1182/blood-2010-07-299644

Published: 2011

Includes: Supplemental data

NARROW

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

Next Generation Sequencing Identifies DNA Methylation Patterns Indicative of Disease Progression in Ph + CML

5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS- demethylation and FAS re-expression, and synergism with FAS-ligand

c-JUN promotes BCR-ABL–induced lymphoid leukemia by inhibiting methylation of the 5′ region of Cdk6

Email alerts

ASH Publications

American Society of Hematology

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

Next Generation Sequencing Identifies DNA Methylation Patterns Indicative of Disease Progression in Ph + CML

5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS- demethylation and FAS re-expression, and synergism with FAS-ligand

c-JUN promotes BCR-ABL–induced lymphoid leukemia by inhibiting methylation of the 5′ region of Cdk6

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only